164 related articles for article (PubMed ID: 34768133)
1. DNA methylation-based surrogates of plasma proteins are associated with Parkinson's disease risk.
Fu KA; Paul KC; Lu AT; Horvath S; Keener AM; Bordelon Y; Bronstein JM; Ritz B
J Neurol Sci; 2021 Dec; 431():120046. PubMed ID: 34768133
[TBL] [Abstract][Full Text] [Related]
2. DNA Methylation Age Acceleration Is Not Associated with Age of Onset in Parkinson's Disease.
Gaare JJ; Brügger K; Nido GS; Tzoulis C
Mov Disord; 2023 Nov; 38(11):2064-2071. PubMed ID: 37551021
[TBL] [Abstract][Full Text] [Related]
3. Accelerated hematopoietic mitotic aging measured by DNA methylation, blood cell lineage, and Parkinson's disease.
Paul KC; Binder AM; Horvath S; Kusters C; Yan Q; Rosario ID; Yu Y; Bronstein J; Ritz B
BMC Genomics; 2021 Sep; 22(1):696. PubMed ID: 34565328
[TBL] [Abstract][Full Text] [Related]
4. Imputation of DNA Methylation Levels in the Brain Implicates a Risk Factor for Parkinson's Disease.
Rawlik K; Rowlatt A; Tenesa A
Genetics; 2016 Oct; 204(2):771-781. PubMed ID: 27466229
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Clock Acceleration Is Linked to Age at Onset of Parkinson's Disease.
Tang X; Gonzalez-Latapi P; Marras C; Visanji NP; Yang W; Sato C; Lang AE; Rogaeva E; Zhang M
Mov Disord; 2022 Sep; 37(9):1831-1840. PubMed ID: 35921480
[TBL] [Abstract][Full Text] [Related]
6. A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events.
Cappozzo A; McCrory C; Robinson O; Freni Sterrantino A; Sacerdote C; Krogh V; Panico S; Tumino R; Iacoviello L; Ricceri F; Sieri S; Chiodini P; McKay GJ; McKnight AJ; Kee F; Young IS; McGuinness B; Crimmins EM; Arpawong TE; Kenny RA; O'Halloran A; Polidoro S; Solinas G; Vineis P; Ieva F; Fiorito G
Clin Epigenetics; 2022 Sep; 14(1):121. PubMed ID: 36175966
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease.
Gonzalez-Latapi P; Bustos B; Dong S; Lubbe S; Simuni T; Krainc D
Ann Neurol; 2024 Jun; 95(6):1162-1172. PubMed ID: 38563317
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation biomarker for cumulative lead exposure is associated with Parkinson's disease.
Paul KC; Horvath S; Del Rosario I; Bronstein JM; Ritz B
Clin Epigenetics; 2021 Mar; 13(1):59. PubMed ID: 33752746
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders.
Nabais MF; Laws SM; Lin T; Vallerga CL; Armstrong NJ; Blair IP; Kwok JB; Mather KA; Mellick GD; Sachdev PS; Wallace L; Henders AK; Zwamborn RAJ; Hop PJ; Lunnon K; Pishva E; Roubroeks JAY; Soininen H; Tsolaki M; Mecocci P; Lovestone S; Kłoszewska I; Vellas B; ; ; Furlong S; Garton FC; Henderson RD; Mathers S; McCombe PA; Needham M; Ngo ST; Nicholson G; Pamphlett R; Rowe DB; Steyn FJ; Williams KL; Anderson TJ; Bentley SR; Dalrymple-Alford J; Fowder J; Gratten J; Halliday G; Hickie IB; Kennedy M; Lewis SJG; Montgomery GW; Pearson J; Pitcher TL; Silburn P; Zhang F; Visscher PM; Yang J; Stevenson AJ; Hillary RF; Marioni RE; Harris SE; Deary IJ; Jones AR; Shatunov A; Iacoangeli A; van Rheenen W; van den Berg LH; Shaw PJ; Shaw CE; Morrison KE; Al-Chalabi A; Veldink JH; Hannon E; Mill J; Wray NR; McRae AF
Genome Biol; 2021 Mar; 22(1):90. PubMed ID: 33771206
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease is associated with DNA methylation levels in human blood and saliva.
Chuang YH; Paul KC; Bronstein JM; Bordelon Y; Horvath S; Ritz B
Genome Med; 2017 Aug; 9(1):76. PubMed ID: 28851441
[TBL] [Abstract][Full Text] [Related]
11. Effects of stressful life-events on DNA methylation in panic disorder and major depressive disorder.
Czamara D; Neufang A; Dieterle R; Iurato S; Arloth J; Martins J; Ising M; Binder EE; Erhardt A
Clin Epigenetics; 2022 Apr; 14(1):55. PubMed ID: 35477560
[TBL] [Abstract][Full Text] [Related]
12. Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson's disease revealed different epigenetic patterns in peripheral blood mononuclear cells.
Kaut O; Schmitt I; Tost J; Busato F; Liu Y; Hofmann P; Witt SH; Rietschel M; Fröhlich H; Wüllner U
Neurogenetics; 2017 Jan; 18(1):7-22. PubMed ID: 27709425
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation and pesticide exposure influence blood DNA methylation signatures in females with early-stage Parkinson's disease.
Schaffner SL; Casazza W; Artaud F; Konwar C; Merrill SM; Domenighetti C; Schulze-Hentrich JM; Lesage S; Brice A; Corvol JC; Mostafavi S; Dennis JK; Elbaz A; Kobor MS;
NPJ Parkinsons Dis; 2024 May; 10(1):98. PubMed ID: 38714693
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation in Parkinson's disease.
Wüllner U; Kaut O; deBoni L; Piston D; Schmitt I
J Neurochem; 2016 Oct; 139 Suppl 1():108-120. PubMed ID: 27120258
[TBL] [Abstract][Full Text] [Related]
15. Epigenome-wide association of myocardial infarction with DNA methylation sites at loci related to cardiovascular disease.
Nakatochi M; Ichihara S; Yamamoto K; Naruse K; Yokota S; Asano H; Matsubara T; Yokota M
Clin Epigenetics; 2017; 9():54. PubMed ID: 28515798
[TBL] [Abstract][Full Text] [Related]
16. Epigenome-wide association study suggests that SNPs in the promoter region of RETN influence plasma resistin level via effects on DNA methylation at neighbouring sites.
Nakatochi M; Ichihara S; Yamamoto K; Ohnaka K; Kato Y; Yokota S; Hirashiki A; Naruse K; Asano H; Izawa H; Matsubara T; Yokota M
Diabetologia; 2015 Dec; 58(12):2781-90. PubMed ID: 26404063
[TBL] [Abstract][Full Text] [Related]
17. Identifying Risk Genes and Interpreting Pathogenesis for Parkinson's Disease by a Multiomics Analysis.
Cheng WW; Zhu Q; Zhang HY
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32967142
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation and brain structure and function across the life course: A systematic review.
Wheater ENW; Stoye DQ; Cox SR; Wardlaw JM; Drake AJ; Bastin ME; Boardman JP
Neurosci Biobehav Rev; 2020 Jun; 113():133-156. PubMed ID: 32151655
[TBL] [Abstract][Full Text] [Related]
19. Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants.
Siu MT; Butcher DT; Turinsky AL; Cytrynbaum C; Stavropoulos DJ; Walker S; Caluseriu O; Carter M; Lou Y; Nicolson R; Georgiades S; Szatmari P; Anagnostou E; Scherer SW; Choufani S; Brudno M; Weksberg R
Clin Epigenetics; 2019 Jul; 11(1):103. PubMed ID: 31311581
[TBL] [Abstract][Full Text] [Related]
20. Hemispheric asymmetry in the human brain and in Parkinson's disease is linked to divergent epigenetic patterns in neurons.
Li P; Ensink E; Lang S; Marshall L; Schilthuis M; Lamp J; Vega I; Labrie V
Genome Biol; 2020 Mar; 21(1):61. PubMed ID: 32151270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
